Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 09, 2017

Astellas Pharma Inc. et al v. Roxane Laboratories, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 10, 2017

    Astellas Sues Roxane Over Generic Cancer Drug ANDA

    Astellas Pharma Inc. is accusing Roxane Laboratories Inc. of filing an abbreviated new drug application for a generic version of its prostate cancer treatment Xtandi that infringes three of its unexpired patents, according to a complaint filed in Delaware federal court Tuesday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login